Amy Finan from the Sabin Vaccine Institute received a call about a Marburg virus outbreak in Rwanda while on vacation. The institute quickly mobilized to send an experimental vaccine to Rwanda, where cases were concentrated among health workers. Despite 64 cases and 15 deaths, the outbreak has been largely controlled due to Rwanda's strong health system and rapid response. The government opted for widespread vaccination among high-risk groups, which may complicate the assessment of the vaccine's effectiveness. Finan emphasized the importance of collaboration and trust in managing health crises.